AbbVie
ABBV
#31
Rank
A$487.22 B
Marketcap
$275.72
Share price
-1.26%
Change (1 day)
14.21%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$220.53 Billion

According to AbbVie's latest financial reports the company's total liabilities are A$220.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$182.46 B2.18%
2022-12-31A$178.57 B-1.25%
2021-12-31A$180.82 B1.14%
2020-12-31A$178.77 B28.66%
2019-12-31A$138.95 B44.38%
2018-12-31A$96.23 B14.38%
2017-12-31A$84.14 B-1.32%
2016-12-31A$85.26 B26.5%
2015-12-31A$67.40 B114.06%
2014-12-31A$31.48 B13.69%
2013-12-31A$27.69 B21.73%
2012-12-31A$22.75 B207.42%
2011-12-31A$7.40 B38.41%
2010-12-31A$5.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$203.78 B-7.60%๐Ÿ‡บ๐Ÿ‡ธ USA
A$122.78 B-44.33%๐Ÿ‡บ๐Ÿ‡ธ USA
A$98.40 B-55.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$133.83 B-39.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$58.01 B-73.69%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.19 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
A$95.82 B-56.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$102.94 B-53.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$1.31 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA